CD1d-reactive NKT cells with an invariant Valpha14 rearrangement (Valpha14i) represent a distinct subset of T lymphocytes that are likely to have important immune regulatory functions. The frequency of Valpha14i NKT cells, and of their human counterpart Valpha24i T cells, is reduced in a variety of autoimmune diseases. Restoration of the valpha14i NKT cells number by means of cell transfer or by forced expression of a transgenic rearranged Valpha14i TCR in the diabetes-prone NOD mice is protective of diabetes. Conversely, the Valpha14i NKT cell deficiency in CD14- NOD mice accelerates disease onset. Altogether, these results suggest that the number of Valpha14i NKT cells is of prime importance for the establishment of immunoregulation. However, little is known regarding the factors governing the maintenance of Valpha14i NKT cells. The overall goal of this grant application is to further understand the mechanisms that control the homeostasis of the Valpha14i NKT cell population in vivo. The experiments proposed examine several aspect of the homeostasis of Valpha14i NKT cells, including the role of IL-15 in the survival of this population, the possible competition between different IL-15 responsive cell populations, the control of the Valpha14i NKT cell number by regulatory CD4+CD25+ T cells and the role of a novel cytokine, IL-21, in Valpha14i NKT cell development and homeostasis. These studies will provide a comprehensive analysis of the mechanisms at play in the maintenance of the Valpha14i NKT cell population in vivo. Understanding such mechanisms might allow for the manipulation of the Valpha14i NKT cell number in vivo that could be exploited for the development of novel immune therapies for cancer and autoimmune diseases.
| Patel, Onisha; Pellicci, Daniel G; Uldrich, Adam P et al. (2011) V?2 natural killer T cell antigen receptor-mediated recognition of CD1d-glycolipid antigen. Proc Natl Acad Sci U S A 108:19007-12 |
| Scott-Browne, James P; White, Janice; Kappler, John W et al. (2009) Germline-encoded amino acids in the alphabeta T-cell receptor control thymic selection. Nature 458:1043-6 |
| Mallevaey, Thierry; Scott-Browne, James P; Matsuda, Jennifer L et al. (2009) T cell receptor CDR2 beta and CDR3 beta loops collaborate functionally to shape the iNKT cell repertoire. Immunity 31:60-71 |
| Pellicci, Daniel G; Patel, Onisha; Kjer-Nielsen, Lars et al. (2009) Differential recognition of CD1d-alpha-galactosyl ceramide by the V beta 8.2 and V beta 7 semi-invariant NKT T cell receptors. Immunity 31:47-59 |
| Gapin, Laurent (2008) The making of NKT cells. Nat Immunol 9:1009-11 |
| Matsuda, Jennifer L; Mallevaey, Thierry; Scott-Browne, James et al. (2008) CD1d-restricted iNKT cells, the 'Swiss-Army knife'of the immune system. Curr Opin Immunol 20:358-68 |
| Marrack, Philippa; Scott-Browne, James P; Dai, Shaodong et al. (2008) Evolutionarily conserved amino acids that control TCR-MHC interaction. Annu Rev Immunol 26:171-203 |
| Chung, Yeonseok; Nurieva, Roza; Esashi, Eiji et al. (2008) A critical role of costimulation during intrathymic development of invariant NK T cells. J Immunol 180:2276-83 |
| Wun, Kwok S; Borg, Natalie A; Kjer-Nielsen, Lars et al. (2008) A minimal binding footprint on CD1d-glycolipid is a basis for selection of the unique human NKT TCR. J Exp Med 205:939-49 |
| Scott-Browne, James P; Matsuda, Jennifer L; Mallevaey, Thierry et al. (2007) Germline-encoded recognition of diverse glycolipids by natural killer T cells. Nat Immunol 8:1105-13 |
Showing the most recent 10 out of 17 publications
